title: Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine.
authors.forename: Jan
authors.initials: J
authors.lastname: Booij
authors.forename: Javier
authors.initials: J
authors.lastname: Arbizu
authors.forename: Jacques
authors.initials: J
authors.lastname: Darcourt
authors.forename: Swen
authors.initials: S
authors.lastname: Hesse
authors.forename: Flavio
authors.initials: F
authors.lastname: Nobili
authors.forename: Pierre
authors.initials: P
authors.lastname: Payoux
authors.forename: Sabina
authors.initials: S
authors.lastname: Pappatà
authors.forename: Klaus
authors.initials: K
authors.lastname: Tatsch
authors.forename: Zuzana
authors.initials: Z
authors.lastname: Walker
authors.forename: Marco
authors.initials: M
authors.lastname: Pagani
mesh_terms: D016229:Amyloid beta-Peptides / Q000378:metabolism*; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism*; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods*
chemical_list: D016229:Amyloid beta-Peptides